SR 271425 is a novel cytotoxic DNA-interacting agent with broad antitumor activity in preclinical models. References: Lockhart AC, Calvo E, Tolcher AW, Rowinsky EK, Shackleton G, Morrison JG, Rafi R, VerMeulen W, Rothenberg ML. A phase I dose-escalation study of SR271425, an intravenously dosed thioxanthone analog, administered weekly in patients with refractory solid tumors. Am J Clin Oncol. 2009 Feb;32(1):9-14. doi: 10.1097/COC.0b013e318178331b. PubMed PMID: 19194116.

纯度：≥98%

CAS：155990-20-8